SIGA Tech rises as US orders antiviral drugs worth $138 mln

SIGA Technologies

28/07/2023 11:37

** Smallpox drugmaker SIGA Technologies Inc's shares
 SIGO.O  up 30.5% at $6.62 premarket
    ** Late Thursday, co said it won a new contract for its
antiviral drug, Tpoxx, from the U.S. Department of Health and
Human Services
    ** Order to deliver ~$113 mln worth of oral Tpoxx treatment
courses and ~$25 mln worth of intravenous formulation 
    ** SIGA expects to fully deliver oral drugs in 2023 and
start delivering IV in 2024
    ** Adds, prior to delivery of Tpoxx IV, it will focus on
fulfilling a previous order
    ** As of last close, stock down ~25% this year

 (Reporting by Pratik Jain in Bengaluru)
 ((Pratik.Jain@thomsonreuters.com;))